Publications scientifiques

Les activités scientifiques de GeNeuro reposent sur plus de 25 années de recherche, effectuée en interne et en collaboration avec des groupes universitaires renommés.

Efficacy and safety of temelimab in multiple sclerosis: Results of a randomized phase 2b and extension study

pHERV-W envelope protein fuels microglial cell-dependent damage of myelinated axons in multiple sclerosis

A High-dose Pharmacokinetic Study of a New IgG4 Monoclonal Antibody Temelimab/GNbAC1 Antagonist of an Endogenous Retroviral Protein pHERV-W Env

ECTRIMS 2109 – Neuroprotective effects of temelimab in relapsing-remitting MS patients extend to 96 weeks

Phase IIb safety and efficacy data on temelimab at week 96 from the ANGEL-MS study

Neural Cell Responses Upon Exposure to Human Endogenous Retroviruses

Variation in proviral content among human genomes mediated by LTR recombination